• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Salix Pharmaceuticals Ltd

+ Add to Watchlist

SLXP:US

118.7200 USD 0.2700 0.23%

As of 13:25:25 ET on 12/19/2014.

Snapshot for Salix Pharmaceuticals Ltd (SLXP)

Open: 118.5400 Day's Range: 117.4200 - 120.4200 Volume: 710,190
Previous Close: 118.4500 52wk Range: 84.1000 - 172.9800 1-Yr Rtn: +38.46%

Stock Chart for SLXP

No chart data available.
  • SLXP:US 118.7450
  • 1D
  • 1M
  • 1Y
118.4500
Interactive SLXP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SLXP

Current P/E Ratio (ttm) 130.0928
Estimated P/E(12/2014) 32.9839
Relative P/E vs. SPX 7.1385
Earnings Per Share (USD) (ttm) 0.9117
Est. EPS (USD) (12/2014) 3.5960
Est. PEG Ratio 1.6915
Market Cap (M USD) 7,558.22
Shares Outstanding (M) 63.72
30 Day Average Volume 3,367,900
Price/Book (mrq) 11.5838
Price/Sale (ttm) 5.4452
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SLXP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SLXP

Salix Pharmaceuticals, Ltd. develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. The Company markets its products to gastroenterologists in the U.S. through its own specialty sales force.

Carolyn J LoganPresident/CEOTimothy J Creech "Tim"Acting CFO/Senior VP:Fin & Admin Svcs
Rick D ScruggsExec VP:Business DevelopmentWilliam P ForbesExec VP:Research & Dev
More Company Profile & Key Executives for SLXP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil